CVRX (CVRx Inc.) Net earnings per share for the last 12 months

Official company branding of CVRx, Inc (CVRX)

The breakthrough status of the Barostim system has secured high loyalty among cardiologists for CVRx, Inc. (CVRX), as evidenced by the 12-month earnings per share history, where the parameter stabilized at -2.00. Management is successfully deploying devices through FDA approvals, while the current expansion of neuromodulators requires capital expenditures despite maintaining positive cash flow dynamics.

CVRX (CVRx, Inc.) Net earnings per share for the last four quarters history from 07/04/2022 to 11/12/2026

CVRX (CVRx Inc.): analytical breakdowns and indicator data

- share price and expert price forecast:
Stock Quotes CVRx, Inc.|CVRX - Broker Consensus Forecast
- business market valuation indicators:
Market Valuation CVRx|CVRX - Value Adjusted for Debt and Cash
- balance sheet net asset value indicators:
Book Value per Share CVRx, Inc.|CVRX - Book Valuation of Business|Market Value to Book Value Ratio cvrx.com|CVRX - Total Business Assets
- debt obligations and liquidity statistics:
Total Debt to Capital CVRx, Inc.|CVRX - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio CVRx, Inc|CVRX - Company Total Debt Obligations|Debts to Book Capitalization CVRx|CVRX - Company Long-Term Liabilities|Company Current Liabilities CVRx, Inc.|Quick Liquidity cvrx.com
- net income and valuation multiples indicators:
CVRX - Final Profit|Future Profit CVRx, Inc.|CVRX - Price to Earnings Multiple|Forward P/E Multiple CVRx|CVRX - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple CVRx|CVRX - Profit before interest, taxes and amortization|Net earnings per share (EPS TTM) CVRx, Inc.|CVRX - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months cvrx.com|CVRX - Earnings per share increase in current year|Expected earnings per share growth for next year CVRx, Inc.
Fundamental company analysis:CVRx, Inc. (CVRX)
Manufactured products of CVRx Inc

Annual earnings per share measures the final efficiency of capital by distributing the aggregate financial result among all shareholders to assess the asset's real return. By analyzing the annual net income per share of CVRx, Inc. (CVRX) on GURU.Markets, an investor can compare the profitability of CVRx, Inc. (CVRX) with its competitors, taking into account the impact of contract electronics manufacturing costs and external clinical trial management on the final profit profile.

Competitor analysis

REGN: Net earnings per share for the last 12 months|IRTC (irhythmtech.com) - Earnings per share for the last 12 months|LNTH (Lantheus) - Net earnings per share for the last 12 months|Mineralys - Earnings per share for the trailing year|HTFL (Heartflow Inc) - Net earnings per share (EPS TTM)|Kestra Medical Corp (KMTS) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Esperion Therapeutics (ESPR)|amarincorp.com - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) AVR (Anteris Technologies)|TNYA - Net earnings per share for the last 12 months|MIST: Net earnings per share for the last 12 months|Net earnings per share for the last four quarters Cardiol Therapeutics CRDL|BEAT: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months tenaxthera.com|Net earnings per share for the last 12 months ADGM|Earnings per share for the last twelve months BCDA|Earnings per share for the last twelve months Catheter Precision Corp (VTAK)|ABIO (arcabio.com) - Earnings per share for the trailing year|Acasti Pharma Inc. - Net earnings per share for the last 12 months|AVTE: Earnings per share for the last 12 months|Verve - Net earnings per share (EPS TTM)|Earnings per share for the trailing year WINT (Windtree Therapeutics)